{
  "personality": null,
  "timestamp": "2025-08-18T04:48:28.463490",
  "category": "Health",
  "news_summary": "Innovative bacteria-based therapies show promise in targeting cancer, while new research reveals Covid-19’s impact on aging blood vessels specifically in women.",
  "news_summary_fr": "Des thérapies innovantes à base de bactéries s'avèrent prometteuses pour lutter contre le cancer, tandis que de nouvelles recherches révèlent l'impact du Covid-19 sur les vaisseaux sanguins vieillissants, en particulier chez les femmes.",
  "news_summary_es": "Las innovadoras terapias basadas en bacterias resultan prometedoras en la lucha contra el cáncer, mientras que una nueva investigación revela el impacto de Covid-19 en el envejecimiento de los vasos sanguíneos, concretamente en las mujeres.",
  "articles": [
    {
      "title": "Trojan horse bacteria sneak cancer-killing viruses into tumors",
      "summary": "Scientists have engineered a groundbreaking cancer treatment that uses bacteria to smuggle viruses directly into tumors, bypassing the immune system and delivering a powerful one-two punch against cancer cells. The bacteria act like Trojan horses, carrying viral payloads to cancer’s core, where the virus can spread and destroy malignant cells. Built-in safety features ensure the virus can’t multiply outside the tumor, offering a promising pathway for safe, targeted therapy.",
      "content": "Researchers at Columbia Engineering have built a cancer therapy that makes bacteria and viruses work as a team. In a study published recently in Nature Biomedical Engineering, the Synthetic Biological Systems Lab shows how their system hides a virus inside a tumor-seeking bacterium, smuggles it past the immune system, and unleashes it inside cancerous tumors.\n\nThe new platform combines the bacteria's tendency to find and attack tumors with the virus's natural preference for infecting and killing cancerous cells. Tal Danino, an associate professor of biomedical engineering at Columbia Engineering, led the team's effort to create the system, which is called CAPPSID (short for Coordinated Activity of Prokaryote and Picornavirus for Safe Intracellular Delivery). Charles M. Rice, an expert in virology at The Rockefeller University, collaborated with the Columbia team.\n\n\"We aimed to enhance bacterial cancer therapy by enabling the bacteria to deliver and activate a therapeutic virus directly inside tumor cells, while engineering safeguards to limit viral spread outside the tumor,\" says co-lead author Jonathan Pabón, an MD/PhD candidate at Columbia.\n\nThe researchers believe that this technology -- validated in mice -- represents the first example of directly engineered cooperation between bacteria and cancer-targeting viruses.\n\nThe approach combines the bacteria's instinct for homing in on tumors with a virus's knack for infecting and killing cancer cells. \"By bridging bacterial engineering with synthetic virology, our goal is to open a path toward multi-organism therapies that can accomplish far more than any single microbe could achieve alone,\" says Zakary S. Singer, a co-lead author and former postdoctoral researcher in Tal Danino's lab.\n\n\"This is probably our most technically advanced and novel platform to date,\" says Danino, who is also affiliated with the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center and Columbia's Data Science Institute.\n\nSneaking past the immune system\n\nOne of the biggest hurdles in oncolytic virus therapy is the body's own defense system. If a patient has antibodies against the virus -- from a prior infection or vaccination -- those antibodies can neutralize it before it reaches a tumor. The Columbia team sidestepped that problem by tucking the virus inside tumor-seeking bacteria.\n\n\"The bacteria act as an invisibility cloak, hiding the virus from circulating antibodies, and ferrying the virus to where it is needed,\" Singer says.\n\nPabón says this strategy is especially important for viruses that people are already exposed to in daily life.\n\n\"Our system demonstrates that bacteria can potentially be used to launch an oncolytic virus to treat solid tumors in patients who have developed immunity to these viruses,\" he says.\n\nTargeting the tumor\n\nThe system's bacterial half is Salmonella typhimurium, a species that naturally migrates to the low-oxygen, nutrient-rich environment inside tumors. Once there, the bacteria invade cancer cells and release the virus directly into the tumor's interior.\n\n\"We programmed the bacteria to act as a Trojan horse by shuttling the viral RNA into tumors and then lyse themselves directly inside of cancer cells to release the viral genome, which could then spread between cancer cells,\" Singer says.\n\nBy exploiting the bacteria's tumor-homing instincts and the virus's ability to replicate inside cancer cells, the researchers created a delivery system that can penetrate the tumor and spread throughout it -- a challenge that has limited both bacteria- and virus-only approaches.\n\nSafeguarding against runaway infections\n\nA key concern with any live virus therapy is controlling its spread beyond the tumor. The team's system solved that problem with a molecular trick: making sure the virus couldn't spread without a molecule it can only get from the bacteria. Since the bacteria stay put in the tumor, this vital component (called a protease) isn't available anywhere else in the body.\n\n\"Spreadable viral particles could only form in the vicinity of bacteria, which are needed to provide special machinery essential for viral maturation in the engineered virus, providing a synthetic dependence between microbes,\" Singer says. That safeguard adds a second layer of control: even if the virus escapes the tumor, it won't spread in healthy tissue.\n\n\"It is systems like these -- specifically oriented towards enhancing the safety of these living therapies -- that will be essential for translating these advances into the clinic,\" Singer says.\n\nFurther research and clinical applications\n\nThis publication marks a significant step toward making this type of bacteria-virus system available for future clinical applications.\n\n\"As a physician-scientist, my goal is to bring living medicines into the clinic,\" Pabón says. \"Efforts toward clinical translation are currently underway to translate our technology out of the lab.\"\n\nDanino, Rice, Singer, and Pabón have filed a patent application (WO2024254419A2) with the U.S. Patent and Trademark Office related to this work.\n\nLooking ahead, the team is testing the approach in a wider range of cancers, using different tumor types, mouse models, viruses, and payloads, with an eye to developing a \"toolkit\" of viral therapies that can sense and respond to specific conditions inside a cell. They are also evaluating how this system can be combined with strains of bacteria that have already demonstrated safety in clinical trials.",
      "url": "https://www.sciencedaily.com/releases/2025/08/250816113522.htm",
      "source": "Latest Science News -- ScienceDaily",
      "published": "2025-08-17",
      "sentiment_score": 0.95,
      "reasoning": "The article reports a significant scientific breakthrough in cancer treatment using engineered bacteria to deliver cancer-killing viruses directly into tumors, overcoming immune system barriers and enhancing safety. This innovative therapy has broad potential impact for cancer patients, is supported by detailed research and validation in animal models, and represents a promising pathway toward clinical application.",
      "category": "Health",
      "personality_title": "Scientists use bacteria to deliver cancer-killing viruses directly into tumors",
      "personality_presentation": "**Context** – Treating cancer is difficult because the body's immune system often blocks viruses that could kill cancer cells. Scientists have been looking for ways to get these helpful viruses safely inside tumors where they can work.\n\n**What happened** – Researchers at Columbia Engineering created a new treatment that uses bacteria to carry viruses straight into tumors. The bacteria act like Trojan horses, hiding the virus from the immune system and bringing it into the tumor. Inside the tumor, the bacteria release the virus, which then infects and kills cancer cells. This method was tested successfully in mice.\n\n**Impact** – This is the first time scientists have made bacteria and viruses work together like this to fight cancer. The bacteria naturally find tumors and the virus kills cancer cells, so combining them helps overcome problems that each had alone. Also, the virus can only grow inside the tumor because it needs a special molecule from the bacteria, which keeps the virus from spreading to healthy parts of the body.\n\n**What's next step** – The team plans to test this therapy on different types of cancer and improve it with other viruses and bacteria already proven safe. They are working to bring this treatment from the lab to clinical trials where it could be tested in people.\n\n**One-sentence takeaway** – Scientists have designed bacteria that sneak cancer-killing viruses into tumors safely, opening a new way to treat cancer more effectively.",
      "personality_title_fr": "Des bactéries utilisées pour transporter des virus qui tuent les cancers directement dans les tumeurs",
      "personality_presentation_fr": "**Contexte** – Traiter le cancer est difficile car le système immunitaire bloque souvent les virus capables de tuer les cellules cancéreuses. Les scientifiques cherchent des moyens pour placer ces virus utiles en toute sécurité à l’intérieur des tumeurs.\n\n**Ce qui s'est passé** – Des chercheurs de Columbia Engineering ont créé un nouveau traitement qui utilise des bactéries pour transporter des virus directement dans les tumeurs. Les bactéries agissent comme des chevaux de Troie, cachant le virus au système immunitaire et l’emmenant dans la tumeur. Une fois à l’intérieur, les bactéries libèrent le virus qui infecte et tue les cellules cancéreuses. Cette méthode a été testée avec succès chez la souris.\n\n**Impact** – C’est la première fois que des bactéries et des virus sont combinés pour lutter ensemble contre le cancer. Les bactéries trouvent naturellement les tumeurs et le virus tue les cellules cancéreuses, ce qui permet de surmonter les limites de chaque méthode prise séparément. De plus, le virus ne peut se multiplier que dans la tumeur, car il a besoin d’une molécule spéciale fournie par les bactéries, ce qui empêche la propagation dans les tissus sains.\n\n**Prochaine étape** – L’équipe prévoit de tester ce traitement sur différents types de cancers et de l’améliorer avec d’autres virus et bactéries déjà sûrs. Ils travaillent à faire passer ce traitement du laboratoire aux essais cliniques sur des patients.\n\n**Une phrase clé** – Des scientifiques ont conçu des bactéries qui transportent en toute sécurité des virus tueurs de cancer dans les tumeurs, ouvrant une nouvelle voie pour soigner le cancer plus efficacement.",
      "personality_title_es": "Científicos usan bacterias para llevar virus que matan el cáncer directamente a los tumores",
      "personality_presentation_es": "**Contexto** – Tratar el cáncer es complicado porque el sistema inmunológico a menudo bloquea los virus que podrían matar las células cancerosas. Los científicos buscan formas de introducir estos virus útiles dentro de los tumores de manera segura.\n\n**Qué pasó** – Investigadores de Columbia Engineering crearon un nuevo tratamiento que usa bacterias para transportar virus directamente a los tumores. Las bacterias actúan como caballos de Troya, escondiendo el virus del sistema inmunológico y llevándolo al tumor. Una vez dentro, las bacterias liberan el virus, que infecta y destruye las células cancerosas. Este método se probó con éxito en ratones.\n\n**Impacto** – Es la primera vez que se combinan bacterias y virus para trabajar juntos contra el cáncer. Las bacterias encuentran naturalmente los tumores y el virus mata las células cancerosas, lo que ayuda a superar los problemas que cada uno tenía por separado. Además, el virus solo puede crecer dentro del tumor porque necesita una molécula especial que le dan las bacterias, evitando que se propague a otras partes sanas del cuerpo.\n\n**Próximo paso** – El equipo planea probar esta terapia en diferentes tipos de cáncer y mejorarla con otros virus y bacterias ya seguros. Están trabajando para llevar este tratamiento del laboratorio a ensayos clínicos en personas.\n\n**Una frase clave** – Científicos diseñaron bacterias que introducen virus que matan el cáncer en los tumores de forma segura, abriendo una nueva forma de tratar el cáncer más eficazmente.",
      "image_url": "public/images/news_image_Trojan-horse-bacteria-sneak-cancer-killing-viruses.png",
      "image_prompt": "A detailed, warm-toned painting of a small, determined Trojan horse shaped like a stylized bacterium carrying a glowing, delicate virus nestled inside, stealthily approaching and entering a vibrant, textured tumor depicted as a fortress with soft, organic walls, surrounded by a subtle shield symbolizing the immune system being gently bypassed."
    },
    {
      "title": "Covid-19 seems to age blood vessels - but only among women",
      "summary": "Women's arteries seem to be stiffer if they have had covid-19, with the same effect not being found among men",
      "content": "Women's arteries seem to be stiffer if they have had covid-19, with the same effect not being found among men\n\nOur arteries get stiffer with age, and covid-19 may not help peterschreiber.media/Alamy\n\nCovid-19 seems to accelerate the ageing of blood vessels, but perhaps only among women.\n\nThe infection has previously been linked to cardiovascular complications, like heart disease, but how it has this effect isn’t entirely clear. To learn more, Rosa Maria Bruno at the Université Paris Cité in France and her colleagues recruited 2390 people, aged 50 on average, from 16 countries – including the UK and US – between September 2020 and February 2022.\n\nAdvertisement\n\nSome of them had tested positive for SARS-CoV-2, the virus that causes covid-19, or had antibodies against it despite not being vaccinated, a sign that they had been infected. The others had only ever tested negative for the virus and had no signs of prior infection.\n\nThe health of their arteries was assessed by measuring how fast a pressure wave passed between the carotid artery in their neck and the femoral arteries in their legs. This is a measure of artery stiffness, which increases naturally with age, with less flexible arteries raising the risk of heart disease.\n\nThe researchers found that among the women in the study, a known SARS-CoV-2 infection was linked to stiffer arteries. This also seemed to increase alongside the severity of their infection. For instance, women who were hospitalised with covid-19 had a vascular age that was around five years older than their uninfected counterparts, rising to 7.5 years among those admitted to intensive care.\n\nFree newsletter Sign up to Health Check Expert insight and news on scientific developments in health, nutrition and fitness, every Saturday. Sign up to newsletter\n\nThe researchers controlled for other factors that can influence artery stiffness, like smoking and obesity.\n\nBut none of these effects occurred among the men. Previous research suggests that women react more strongly to infections than men and are less able to dial down their immune response, which could lead to damaging inflammation. Bruno says she was expecting to see some difference between the sexes, but not this much.\n\nThe findings could also shed some light on long covid, which seems to be more common among women. At a six-month follow-up, the stiffness of the women’s arteries had improved slightly, but was still particularly high among those with lingering covid-19-related complications. “Here we have demonstrated there is something measurable in the blood vessels that corresponds to the symptoms of long-covid patients,” says Bruno.\n\nIt’s possible that some of the people in the uninfected group may have unknowingly had a mild infection, affecting the validity of the results.\n\nNevertheless, Vassilios Vassiliou at the University of East Anglia in the UK says the study is robust and could help identify people with long covid. “The study is the first large international multicentre investigation to demonstrate that covid-19 is associated with accelerated vascular ageing,” he says. “The findings may also contribute to a better mechanistic understanding of post covid-19 syndrome, potentially paving the way for targeted pharmacological interventions.”",
      "url": "https://www.newscientist.com/article/2492805-covid-19-seems-to-age-blood-vessels-but-only-among-women/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home",
      "source": "New Scientist - Home",
      "published": "2025-08-18",
      "sentiment_score": 0.75,
      "reasoning": "The article reports a significant scientific study identifying a measurable impact of covid-19 on women's vascular health, which advances understanding of long covid and could lead to targeted treatments benefiting many people worldwide.",
      "category": "Health",
      "personality_title": "Covid-19 linked to faster artery aging in women, new study finds",
      "personality_presentation": "**Context** – Covid-19 has been connected to heart problems, but scientists wanted to understand how the virus affects blood vessels, especially in different genders.\n\n**What happened** – Researchers studied 2,390 people from 16 countries between 2020 and 2022. They measured artery stiffness by checking how fast a pressure wave moved through arteries in the neck and legs. The study showed that women who had covid-19 had stiffer arteries, which is a sign of faster aging. This effect was stronger in women with severe illness. Men did not show this change.\n\n**Impact** – This is important because stiffer arteries increase the risk of heart disease. The research also helps explain why long covid symptoms might be more common in women. It shows a clear, measurable change in blood vessels linked to covid-19, which was not known before.\n\n**What's next step** – Scientists hope these findings will help doctors identify people at risk of long covid and develop treatments that target blood vessel damage caused by the virus.\n\n**One-sentence takeaway** – Covid-19 appears to speed up artery aging in women, providing new clues to long covid and potential treatments.",
      "personality_title_fr": "Le covid-19 accélère le vieillissement des artères chez les femmes, révèle une nouvelle étude",
      "personality_presentation_fr": "**Contexte** – Le covid-19 a été lié à des problèmes cardiaques, mais les scientifiques voulaient comprendre comment le virus affecte les vaisseaux sanguins, surtout selon le sexe.\n\n**Ce qui s'est passé** – Des chercheurs ont étudié 2 390 personnes de 16 pays entre 2020 et 2022. Ils ont mesuré la rigidité des artères en observant la vitesse d'une onde de pression dans les artères du cou et des jambes. L'étude a montré que les femmes ayant eu le covid-19 avaient des artères plus rigides, signe d'un vieillissement accéléré. Cet effet était plus fort chez les femmes gravement malades. Les hommes n'ont pas montré ce changement.\n\n**Impact** – Cela est important car des artères plus rigides augmentent le risque de maladies cardiaques. La recherche aide aussi à comprendre pourquoi les symptômes du covid long sont plus fréquents chez les femmes. Elle montre un changement clair et mesurable des vaisseaux sanguins lié au covid-19, inconnu auparavant.\n\n**Prochaine étape** – Les scientifiques espèrent que ces résultats aideront les médecins à repérer les personnes à risque de covid long et à développer des traitements ciblant les dégâts aux vaisseaux causés par le virus.\n\n**Résumé en une phrase** – Le covid-19 semble accélérer le vieillissement des artères chez les femmes, ouvrant la voie à de nouvelles pistes pour le covid long et ses traitements.",
      "personality_title_es": "El covid-19 acelera el envejecimiento de las arterias en mujeres, según un estudio",
      "personality_presentation_es": "**Contexto** – El covid-19 se ha relacionado con problemas cardíacos, pero los científicos querían entender cómo el virus afecta los vasos sanguíneos, especialmente en diferentes sexos.\n\n**Qué pasó** – Investigadores estudiaron a 2,390 personas de 16 países entre 2020 y 2022. Midieron la rigidez de las arterias observando la velocidad de una onda de presión en las arterias del cuello y las piernas. El estudio mostró que las mujeres que tuvieron covid-19 tenían arterias más rígidas, señal de un envejecimiento más rápido. Este efecto fue mayor en mujeres con enfermedad grave. Los hombres no mostraron este cambio.\n\n**Impacto** – Esto es importante porque las arterias rígidas aumentan el riesgo de enfermedades cardíacas. La investigación también ayuda a explicar por qué los síntomas de covid largo son más comunes en mujeres. Muestra un cambio claro y medible en los vasos sanguíneos relacionado con el covid-19, antes desconocido.\n\n**Próximo paso** – Los científicos esperan que estos hallazgos ayuden a los médicos a identificar a personas en riesgo de covid largo y a desarrollar tratamientos que apunten al daño vascular causado por el virus.\n\n**Frase clave** – El covid-19 parece acelerar el envejecimiento de las arterias en mujeres, ofreciendo nuevas pistas para el covid largo y sus tratamientos.",
      "image_url": "public/images/news_image_Covid-19-seems-to-age-blood-vessels-but-only-among.png",
      "image_prompt": "A detailed, warm-toned painting of two stylized, intertwined arteries shaped like gentle flowing ribbons—one subtly thickened and textured with fine cracks symbolizing stiffness and aging, glowing softly in warm reds and pinks to represent female arteries affected by Covid-19, while the other artery remains smooth and flexible in cooler muted tones, set against a simple, natural beige background."
    }
  ]
}